FDA Requests Recall of Florida Compounder’s Sterile Products

Drug Industry Daily
A A
Acting FDA Commissioner Ned Sharpless flagged “significant quality and sterility concerns” surrounding a Melbourne, Florida outsourcing facility on Tuesday, as the agency sought a recall of all sterile products compounded at the facility.

To View This Article:

Login

Subscribe To Drug Industry Daily